Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
The purpose of this funding opportunity from the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Mental Health (NIMH), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) is to support the development of new and innovative on-demand, event-driven and long-acting systemic and non-systemic MPTs. These MPTs can deliver HIV and other STIs prevention, HIV and pregnancy prevention (hormonal and non-hormonal methods), or other STI and pregnancy prevention for cis and transgendered individuals of all ages. NIAID will also support MPT drug formulation development and socio and biobehavioral research to promote increased MPT adoption and use. Additional details can be found on www.GRANTS.gov by searching within “Search Grants” for Funding Opportunity Number: PAR-19-209, then clicking on the opportunity number.
• Funding Opportunity #: PAR-19-209
• Open Date: 6 April 2019
• Letter of Intent Due: 6 April 2019
• Application Due: 6 May 2019 by 5:00 p.m. local time of applicant organization
HIV Prevention Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)
The purpose of this funding opportunity announcement (FOA) is to solicit applications for HIV Prevention Clinical Trials Network Leadership and Operations Center (LOC). The National Institute of Allergy and Infectious Diseases (NIAID) and NIH have advanced understanding of disease mechanisms and used basic science to create opportunities for the discovery, development, and clinical evaluation of novel prevention and treatment strategies. In order to reduce HIV incidence at a population level, research must focus on advancing a range of products and strategies to meet the needs of populations vulnerable to HIV infection. These include research priority areas like ARV-based HIV prevention products and delivery methods, MPTs with anti-infective and contraceptive properties, as well as integrated biomedical and sociobehavioral prevention strategies. Only AIDS applications will be accepted. Additional details can be found on www.GRANTS.gov by searching within “Search Grants” for Funding Opportunity Number: RFA-AI-19-005, then clicking on the opportunity number.
• Funding Opportunity #: RFA-AI-19-005
• Open Date: 1 July 2019
• Letter of Intent Due: 1 July 2019
• Application Due: 1 August 2019 by 5:00 p.m. local time of applicant organization
